Drug Trial Radar · NCT00559585
Methotrexate-Inadequate Response Study
Last checked: Nov 20, 2026Latest source record: Nov 9, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,492
Actual
Start
Jan 2008
Primary completion
Nov 2009
Study completion Sep 2014
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Nov 16, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether a weekly subcutaneous dose of abatacept yields clinical efficacy comparable to that of monthly intravenous doses of abatacept in participants with rheumatoid arthritis and an inadequate response to current methotrexate therapy.
Conditions
- Rheumatoid Arthritis (RA)
Interventions
Subcutaneous (SC) AbataceptDrug
Participants received 125 mg weekly SC abatacept injections (with an intravenous \[IV\] abatacept loading dose on Day 1, based on weight). A double-dummy design was used to protect the blind, thus, participants also received IV injections of placebo (IV Placebo) with the exception that on Day 1 a loading dose of IV abatacept replaced the IV Placebo treatment.
Intravenous (IV) AbataceptDrug
Participants received IV abatacept infusions on Days 1, 15, 29, and every 28 days, thereafter. A double-dummy design was used to protect the blind, thus, participants also received SC injections of placebo (SC Placebo). 500mg (for body weight up to 60 kg) 750 mg (body weight between 61 and 100 kg) 1g (body weight above 100 kg)infusions
Primary outcomes
What the sponsor says the trial is designed to measure.
- Double-blind Period: Number of Participants Achieving American College of Rheumatology (ACR) 20 Response at Day 169Time frame: Day 169
- Anti-TNF Failure Sub-Study Double Blind Period : Number of Participants With Positive Anti-abatacept or Anti-Cytotoxic T Lymphocyte Antigen 4-T Cell (CTLA4-T) Response in Anti-TNF Failure PopulationTime frame: Days 85, and 169 and postvisits on Days 28, 56, and 85
Locations
203 sites in 24 countries. Site status is shown where the registry gives one.
Rheumatology Associates, Pc
Birmingham, Alabama
Coastal Clinical Research, Inc
Mobile, Alabama
Advanced Arthritis Care & Research
Scottsdale, Arizona
Catalina Pointe Clinical Research, Inc.
Tucson, Arizona
St. Joseph'S Mercy Clinic
Hot Springs, Arkansas
Talbert Medical Group
Huntington Beach, California
Allergy & Rheumatology Medical Clinic, Inc.
La Jolla, California
Valerius Medical Group &Research Ctr. Of Greater Long Beach
Long Beach, California
Stanford University School Of Medicine
Palo Alto, California
San Diego Arthritis Medical Clinic
San Diego, California
Boulder Medical Center
Boulder, Colorado
Arthritis Assoc And Osteo Ctr Of Col Sprgs
Colorado Springs, Colorado
Denver Arthritis Clinic
Denver, Colorado
Arthritis Center Of The Rockies, Pc
Loveland, Colorado
Guadagnoli, Germano
Bridgeport, Connecticut
Joao Nascimento
Bridgeport, Connecticut
Clinical Research Center Of Ct/Ny
Danbury, Connecticut
Arthritis And Rheumatic Disease Specialties
Aventura, Florida
Arthritis & Osteoporosis Treatment Center, Pa
Orange Park, Florida
Rheumatology Associates Of Central Florida
Orlando, Florida
The Arthritis Center
Palm Harbor, Florida
Sarasota Arthritis Research Center
Sarasota, Florida
Arthritis & Rheumatology Of Georgia,Pc
Atlanta, Georgia
Boise Rheumatology/ Intermountain Research Center, Inc
Boise, Idaho
Coeur D'Alene Arthrit Clin
Coeur d'Alene, Idaho
Quincy Medical Group
Quincy, Illinois
Rockford Orthopedic Associates, Ltd.
Rockford, Illinois
The Arthritis Center
Springfield, Illinois
Klein And Associates, M.D., Pa
Cumberland, Maryland
Clinical Pharmacology Study Group
Worcester, Massachusetts
Shores Rheumatology, P. C.
Saint Clair Shores, Michigan
Arthritis Assoicates Of Mississippi
Jackson, Mississippi
Kansas City Internal Medicine
Lee's Summit, Missouri
Physician Research Collaboration, Llc
Lincoln, Nebraska
Allergy And Arthritis Associates
Dover, New Jersey
Albuquerque Clinical Trials, Inc.
Albuquerque, New Mexico
Albuquerque Rehabilitation & Rheumatology Pc
Albuquerque, New Mexico
The Center For Rheumatology, Llp
Albany, New York
Southern Tier Arthritis & Rheumatism
Olean, New York
Arthritis Health Associates
Syracuse, New York
Showing 40 of 203 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.